Page last updated: 2024-10-30

mesalamine and Abnormalities, Congenital

mesalamine has been researched along with Abnormalities, Congenital in 3 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Wensink, MJ1
Streett, SE1
Damkier, P1
Lindahl-Jacobsen, R1
Kjeldsen, J1
Eisenberg, ML1
Ban, L1
Tata, LJ1
Fiaschi, L1
Card, T1
Nørgård, B1
Pedersen, L1
Christensen, LA1
Sørensen, HT1

Other Studies

3 other studies available for mesalamine and Abnormalities, Congenital

ArticleYear
Balsalazide Exposure During the Development of Fertilizing Sperm May Be Associated With Offspring Birth Defects.
    Inflammatory bowel diseases, 2022, 10-03, Volume: 28, Issue:10

    Topics: Congenital Abnormalities; Humans; Male; Mesalamine; Phenylhydrazines; Semen; Spermatozoa

2022
Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Gastroenterology, 2014, Volume: 146, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Azathioprine; Congenital Abnormali

2014
Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
    The American journal of gastroenterology, 2007, Volume: 102, Issue:7

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Confidence Intervals; Congenital Abnorma

2007